Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report. Cancer biologists are keenly aware of this statistic, as it drives innovations that revolutionize cancer care—innovations like immunotherapy. Immunotherapy fights cancer using the body's own immune…
Lawmakers questioned Nicole Saphier, MD, on abortion bans, vaccines and other preventive health issues during Wednesday’s hearing to be the next surgeon general. In May, President Donald J. Trump announced Saphier would replace Casey Means, MD, as his nominee for the position after months of a stalled process. In a…
Exercise Plan Linked to 23% Lower Death Risk in Cancer Patients Newsweek
Editor’s note: This is part three of a Healio Dermatology back-to-school skin series, where experts discuss common adolescent skin conditions, treatments and trends. Read part one here. Read part two here. Sunscreen may not top the back-to-school shopping list for some parents as children return to classrooms, but…
Казахстанцам доступны 150 наименований современных противоопухолевых препаратов Казинформ
As climate change drives more frequent and intense wildfires, researchers at the Icahn School of Medicine at Mount Sinai have published two large-scale studies showing that wildfire smoke may pose greater health risks than other sources of air pollution, with higher risks of hospitalization for cardiovascular and…
FDA Approves sNDA for Taletrectinib in ROS1+ NSCLC Oncology Nursing News
Мурашко: «Идет рост выявления рака на ранних стадиях» evening-kazan.ru
Мурашко: «Идет рост выявления рака на ранних стадиях» Вечерняя Казань
Talks with Docs: Kelly Hewitt, MD | Breast Surgical Oncology and Robotic Surgery University of Utah Health
A decade of advances in ovarian cancer: Julie's story Roswell Park Comprehensive Cancer Center
Women with a higher body mass index (BMI) in early adulthood may have a lower risk of developing breast cancer after menopause because of lasting changes in the structure of their breast tissue, according to researchers at The University of Manchester and Manchester University NHS Foundation Trust.
Altis Labs’ AI software detected treatment benefit earlier in oncology trial Clinical Trials Arena